Gas chromatography/tandem mass spectrometry detection of extracellular kynurenine and related metabolites in normal and lesioned rat brain

Analytical Biochemistry

Volumn 421, Issue 2, 2012, Pages 573-581

  Notarangelo, Francesca M ^a   Wu, Hui Qiu ^a   Macherone, Anthony ^b   Graham, David R ^c   Schwarcz, Robert ^a  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

^b AGILENT TECHNOLOGIES   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

3 Hydroxykynurenine; Microdialysis; Quinolinic acid; Selective reaction monitoring; Tandem mass spectrometry; Tryptophan

Indexed keywords

AMINO ACIDS; DIALYSIS; MASS SPECTROMETRY; METABOLITES; PYRIDINE; RATS;

3-HYDROXYKYNURENINE; MICRO-DIALYSIS; SELECTIVE REACTION MONITORING; TANDEM MASS SPECTROMETRY; TRYPTOPHAN;

GAS CHROMATOGRAPHY;

3 HYDROXYKYNURENINE; KYNURENINE; QUINOLINIC ACID; TRYPTOPHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DAMAGE; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG EFFECT; DRUG STRUCTURE; EXTRACELLULAR MATRIX; GAS CHROMATOGRAPHY; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; TANDEM MASS SPECTROMETRY;

RATTUS;

EID: 84862785742     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2011.12.032     Document Type: Article

References (62)

1. J.R. Moffett, M.A. Namboodiri, Tryptophan and the immune response, Immunol. Cell Biol. 81 (2003) 247-265. (Pubitemid 36904332)
2. A. Gonzalez, N. Varo, E. Alegre, A. Diaz, I. Melero, Immunosuppression routed via the kynurenine pathway: a biochemical and pathophysiologic approach, Adv. Clin. Chem. 45 (2008) 155-197.
3. G.F. Oxenkrug, Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism, Ann. N.Y. Acad. Sci. 1199 (2010) 1-14.
4. Y. Wang, H. Liu, G. McKenzie, P.K. Witting, J.P. Stasch, M. Hahn, D. Changsirivathanathamrong, B.J. Wu, H.J. Ball, S.R. Thomas, V. Kapoor, D.S. Celermajer, A.L. Mellor, J.F. Keaney Jr., N.H. Hunt, R. Stocker, Kynurenine is an endothelium-derived relaxing factor produced during inflammation, Nat. Med. 16 (2010) 279-285.
5. G. Costantino, New promises for manipulation of kynurenine pathway in cancer and neurological diseases, Expert Opin. Ther. Targets 13 (2009) 247-258.
6. A.C. Foster, A. Vezzani, E.D. French, R. Schwarcz, Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid, Neurosci. Lett. 48 (1984) 273-278. (Pubitemid 14054435)
7. M. Kessler, T. Terramani, G. Lynch, M. Baudry, A glycine site associated with Nmethyl- D-aspartic acid receptors: characterization and identification of a new class of antagonists, J. Neurochem. 52 (1989) 1319-1328. (Pubitemid 19085960)
8. M.N. Perkins, T.W. Stone, An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid, Brain Res. 247 (1982) 184-187. (Pubitemid 12028646)
9. T.W. Stone, M.N. Perkins, Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS, Eur. J. Pharmacol. 72 (1981) 411-412. (Pubitemid 11081065)
10. R. Schwarcz, W.O. Whetsell Jr., R.M. Mangano, Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain, Science 219 (1983) 316-318. (Pubitemid 13222319)
11. G.I. Giles, C.A. Collins, T.W. Stone, C. Jacob, Electrochemical and in vitro evaluation of the redox properties of kynurenine species, Biochem. Biophys. Res. Commun. 300 (2003) 719-724. (Pubitemid 36268896)
12. G. Leipnitz, C. Schumacher, K.B. Dalcin, K. Scussiato, A. Solano, C. Funchal, C.S. Dutra-Filho, A.T. Wyse, C.M. Wannmacher, A. Latini, M. Wajner, In vitro evidence for an antioxidant role of 3-hydroxykynurenine and 3- hydroxyanthranilic acid in the brain, Neurochem. Int. 50 (2007) 83-94. (Pubitemid 44911063)
13. F. Moroni, Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites, Eur. J. Pharmacol. 375 (1999) 87-100. (Pubitemid 29317595)
14. H. Németh, J. Toldi, L. Vécsei, Role of kynurenines in the central and peripheral nervous systems, Curr. Neurovasc. Res. 2 (2005) 249-260.
15. Y. Chen, V. Meininger, G.J. Guillemin, Recent advances in the treatment of amyotrophic lateral sclerosis: Emphasis on kynurenine pathway inhibitors, Cent. Nerv. Syst. Agents Med. Chem. 9 (2009) 32-39.
16. R. Schwarcz, R. Pellicciari, Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities, J. Pharmacol. Exp. Ther. 303 (2002) 1-10.
17. S. Erhardt, S.K. Olsson, G. Engberg, Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders, CNS Drugs 23 (2009) 91-101.
18. D. Zwilling, S.Y. Huang, K.V. Sathyasaikumar, F.M. Notarangelo, P. Guidetti, H.Q. Wu, J. Lee, J. Truong, Y. Andrews-Zwilling, E.W. Hsieh, J.Y. Louie, T. Wu, K. Scearce-Levie, C. Patrick, A. Adame, F. Giorgini, S. Moussaoui, G. Laue, A. Rassoulpour, G. Flik, Y. Huang, J.M. Muchowski, E. Masliah, R. Schwarcz, P.J. Muchowski, Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration, Cell 145 (2011) 863-874.
19. E. Vamos, A. Pardutz, P. Klivenyi, J. Toldi, L. Vécsei, The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection, J. Neurol. Sci. 283 (2009) 21-27.
20. E.M. Gál, A.D. Sherman, L-Kynurenine: Its synthesis and possible regulatory function in brain, Neurochem. Res. 5 (1980) 223-239. (Pubitemid 10134133)
21. S. Fukui, R. Schwarcz, S.I. Rapoport, Y. Takada, Q.R. Smith, Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism, J. Neurochem. 56 (1991) 2007-2017.
22. G.J. Guillemin, K.M. Cullen, C.K. Lim, G.A. Smythe, B. Garner, V. Kapoor, O. Takikawa, B.J. Brew, Characterization of the kynurenine pathway in human neurons, J. Neurosci. 27 (2007) 12884-12892. (Pubitemid 350161746)
23. M.P. Heyes, P.F. Morrison, Quantification of local de novo synthesis versus blood contributions to quinolinic acid concentrations in brain and systemic tissues, J. Neurochem. 68 (1997) 280-288. (Pubitemid 26427318)
24. T. Kita, P.F. Morrison, M.P. Heyes, S.P. Markey, Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain, J. Neurochem. 82 (2002) 258-268. (Pubitemid 34774617)
25. J.F. Reinhard Jr., J.B. Erickson, E.M. Flanagan,Quinolinicacid inneurologicaldisease: opportunities for novel drug discovery, Adv. Pharmacol. 30 (1994) 85-127.
26. P.B. Bergqvist, M.P. Heyes, G. Apelqvist, R.F. Butterworth, F. Bengtsson, Brain extracellular quinolinic acid in chronic experimental hepatic encephalopathy as assessed by in vivo microdialysis: acute effects of L-tryptophan, Neuropsychopharmacology 15 (1996) 382-389. (Pubitemid 26342921)
27. K.E. Beagles, P.F. Morrison, M.P. Heyes, Quinolinic acid in vivo synthesis rates, extracellular concentrations, and intercompartmental distributions in normal and immune-activated brain as determined by multiple-isotope microdialysis, J. Neurochem. 70 (1998) 281-291. (Pubitemid 28020854)
28. K.J. Swartz, M.J. During, A. Freese, M.F. Beal, Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors, J. Neurosci. 10 (1990) 2965-2973.
29. H.Q. Wu, H. Baran, U. Ungerstedt, R. Schwarcz, Kynurenic acid in the quinolinate-lesioned rat hippocampus: studies in vitro and in vivo, Eur. J. Neurosci. 4 (1992) 1264-1270. (Pubitemid 23044621)
30. M.C. Potter, G.I. Elmer, R. Bergeron, E.X. Albuquerque, P. Guidetti, H.Q. Wu, R. Schwarcz, Reduction of endogenous kynurenic acid formation enhances extracellular glutamate, hippocampal plasticity, and cognitive behavior, Neuropsychopharmacology 35 (2010) 1734-1742.
31. P.H. Hutson, G.S. Sarna, B.D. Kantamaneni, G. Curzon, Monitoring the effect of a tryptophan load on brain indole metabolism in freely moving rats by simultaneous cerebrospinal fluid sampling and brain dialysis, J. Neurochem. 44 (1985) 1266-1273. (Pubitemid 15107068)
32. H. Landolt, T.W. Lutz, H. Langemann, D. Stauble, A. Mendelowitsch, O. Gratzl, C.G. Honegger, Extracellular antioxidants and amino acids in the cortex of the rat: monitoring by microdialysis of early ischemic changes, J. Cereb. Blood Flow Metab. 12 (1992) 96-102.
33. J.A. Eckstein, G.M. Ammerman, J.M. Reveles, B.L. Ackermann, Simultaneous profiling of multiple neurochemical pathways from a single cerebrospinal fluid sample using GC/MS/MS with electron capture detection, J. Mass Spectrom. 43 (2008) 782-790. (Pubitemid 351954812)
34. T.H. Risby, Use of negative chemical ionization mass spectrometry for the trace analysis of metals, Environ. Health Perspect. 36 (1980) 39-46. (Pubitemid 11219355)
35. E. Watson, S. Wilk, Derivatization and gas chromatographic determination of some biologically important acids in cerebrospinal fluid, Anal. Biochem. 59 (1974) 441-451.
36. R. Schwarcz, D. Scholz, J.T. Coyle, Structure-activity relations for the neurotoxicity of kainic acid derivatives and glutamate analogues, Neuropharmacology 17 (1978) 145-151. (Pubitemid 8282474)
37. E.M. Gál, A.D. Sherman, Synthesis and metabolism of L-kynurenine in rat brain, J. Neurochem. 30 (1978) 607-613. (Pubitemid 8291438)
38. D.B. Naritsin, R.L. Boni, S.P. Markey, Pentafluorobenzylation method for quantification of acidic tryptophan metabolites using electron capture negative ion mass spectrometry, Anal. Chem. 67 (1995) 863-870.
39. G.A. Smythe, O. Braga, B.J. Brew, R.S. Grant, G.J. Guillemin, S.J. Kerr, D.W. Walker, Concurrent quantification of quinolinic, picolinic, and nicotinic acids using electron-capture negative-ion gas chromatography-mass spectrometry, Anal. Biochem. 301 (2002) 21-26. (Pubitemid 34113674)
40. M.J. During, A. Freese, M.P. Heyes, K.J. Swartz, S.P. Markey, R.H. Roth, J.B. Martin, Neuroactive metabolites of l-tryptophan, serotonin, and quinolinic acid in striatal extracellular fluid: effect of tryptophan loading, FEBS Lett. 247 (1989) 438-444. (Pubitemid 19129294)
41. M.A. Malone, H. Zuo, S.M. Lunte, M.R. Smyth, Determination of tryptophan and kynurenine in brain microdialysis samples by capillary electrophoresis with electrochemical detection, J. Chromatogr. A (1995) 73-80.
42. K. Saito, S. Fujigaki, M.P. Heyes, K. Shibata, M. Takemura, H. Fujii, H. Wada, A. Noma, M. Seishima, Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency, Am. J. Physiol. Renal Physiol. 279 (2000) F565-F572.
43. A. Okuno, T. Fukuwatari, K. Shibata, High tryptophan diet reduces extracellular dopamine release via kynurenic acid production in rat striatum, J. Neurochem. 118 (2011) 796-805.
44. T. Kaper, L.L. Looger, H. Takanaga, M. Platten, L. Steinman, W.B. Frommer, Nanosensor detection of an immunoregulatory tryptophan influx/kynurenine efflux cycle, PLoS Biol. 5 (2007) e257.
45. D. Pawlak, A. Tankiewicz, W. Buczko, Kynurenine and its metabolites in the rat with experimental renal insufficiency, J. Physiol. Pharmacol. 52 (2001) 755-766. (Pubitemid 34042360)
46. C.L. Eastman, T.R. Guilarte, J.R. Lever, Uptake of 3-hydroxykynurenine measured in rat brain slices and in a neuronal cell line, Brain Res. 584 (1992) 110-116.
47. M.P. Heyes, K. Saito, S.P. Markey, Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid, Biochem. J. 283 (1992) 633-635.
48. M.P. Heyes, K. Saito, J.S. Crowley, L.E. Davis, M.A. Demitrack, M. Der, L.A. Dilling, J. Elia, M.J. Kruesi, A. Lackner, Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease, Brain 115 (1992) 1249-1273.
49. G.J. Guillemin, S.J. Kerr, L.A. Pemberton, D.G. Smith, G.A. Smythe, P.J. Armati, B.J. Brew, IFN-b1b induces kynurenine pathway metabolism in human macrophages: potential implications for multiple sclerosis treatment, J. Interferon Cytokine Res. 21 (2001) 1097-1101. (Pubitemid 34114289)
50. A. Chiarugi, R. Carpenedo, F. Moroni, Kynurenine disposition in blood and brain of mice: effects of selective inhibitors of kynurenine hydroxylase and of kynureninase, J. Neurochem. 67 (1996) 692-698. (Pubitemid 26255666)
51. L. Amori, P. Guidetti, R. Pellicciari, Y. Kajii, R. Schwarcz, On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo, J. Neurochem. 109 (2009) 316-325.
52. C. Speciale, U. Ungerstedt, R. Schwarcz, Production of extracellular quinolinic acid in the striatum studied by microdialysis in unanesthetized rats, Neurosci. Lett. 104 (1989) 345-350. (Pubitemid 19231158)
53. G. Cannazza, M. Baraldi, D. Braghiroli, A. Tait, C. Parenti, High-performance liquid chromatographic method for the quantification of anthranilic and 3- hydroxyanthranilic acid in rat brain dialysate, J. Pharm. Biomed. Anal. 32 (2003) 287-293. (Pubitemid 36588729)
54. R. Schwarcz, P. Guidetti, K.V. Sathyasaikumar, P.J. Muchowski, Of mice, rats, and men: revisiting the quinolinic acid hypothesis of Huntington's disease, Prog. Neurobiol. 90 (2010) 230-245.
55. H.Q. Wu, K. Fuxe, R. Schwarcz, Neuronal A1 receptors mediate increase in extracellular kynurenic acid after local intrastriatal adenosine infusion, J. Neurochem. 90 (2004) 621-628. (Pubitemid 38989392)
56. 3H]kynurenine in the rat brain in vivo: Evidence for the existence of a functional kynurenine pathway, J. Neurochem. 65 (1995) 2621-2632.
57. D.S. Reynolds, A.J. Morton, Changes in blood-brain barrier permeability following neurotoxic lesions of rat brain can be visualised with trypan blue, J. Neurosci. Methods 79 (1998) 115-121. (Pubitemid 28248248)
58. D. Alberati-Giani, P. Ricciardi-Castagnoli, C. Köhler, A.M. Cesura, Regulation of the kynurenine metabolic pathway by interferon-γ in murine cloned macrophages and microglial cells, J. Neurochem. 66 (1996) 996-1004. (Pubitemid 26065895)
59. C. Speciale, R. Schwarcz, On the production and disposition of quinolinic acid in rat brain and liver slices, J. Neurochem. 60 (1993) 212-218. (Pubitemid 23006720)
60. E. Lehrmann, A. Molinari, C. Speciale, R. Schwarcz, Immunohistochemical visualization of newly formed quinolinate in the normal and excitotoxically lesioned rat striatum, Exp. Brain Res. 141 (2001) 389-397. (Pubitemid 33071184)
61. I. Wonodi, O.C. Stine, K.V. Sathyasaikumar, R.C. Roberts, B.D. Mitchell, L.E. Hong, Y. Kajii, G.K. Thaker, R. Schwarcz, Downregulated kynurenine 3- monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes, Arch. Gen. Psychiatry 68 (2011) 665-674.
62. R. Dantzer, J.C. O'Connor, G.G. Freund, R.W. Johnson, K.W. Kelley, From inflammation to sickness and depression: when the immune system subjugates the brain, Nat. Rev. Neurosci. 9 (2008) 46-56. (Pubitemid 350295688)